Search

Your search keyword '"Flannery, Brendan"' showing total 684 results
Start Over Author "Flannery, Brendan" Language english
684 results on '"Flannery, Brendan"'

2. Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines

Author

Liu, Feng, Gross, F. Liaini, Joshi, Sneha, Gaglani, Manjusha, Naleway, Allison L., Murthy, Kempapura, Groom, Holly C., Wesley, Meredith G., Edwards, Laura J., Grant, Lauren, Kim, Sara S., Sambhara, Suryaprakash, Gangappa, Shivaprakash, Tumpey, Terrence, Thompson, Mark G., Fry, Alicia M., Flannery, Brendan, Dawood, Fatimah S., and Levine, Min Z.

Published
2024
Full Text
View/download PDF

3. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022

Author

Ahmed, Faruque, Nowalk, Mary Patricia, Zimmerman, Richard K., Bear, Todd, Grijalva, Carlos G., Talbot, H. Keipp, Florea, Ana, Tartof, Sara Y., Gaglani, Manjusha, Smith, Michael, McLean, Huong Q., King, Jennifer P., Martin, Emily T., Monto, Arnold S., Phillips, C. Hallie, Wernli, Karen J., Flannery, Brendan, Chung, Jessie R., and Uzicanin, Amra

Subjects
Epidemics -- Statistics -- Risk factors -- United States, Respiratory tract diseases -- Statistics -- Risk factors, Influenza -- Statistics -- Risk factors, Presenteeism (Labor) -- Statistics -- Health aspects, Health
Abstract

COVID-19 cases in the United States, first reported on January 22, 2020, began to increase in March 2020 (1). The pandemic resulted in a substantial number of employed persons being [...]

Published
2023
Full Text
View/download PDF

5. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022

Author

Kniss, Krista, Sumner, Kelsey M., Tastad, Katie J., Lewis, Nathaniel M., Jansen, Lauren, Julian, Derek, Reh, Mike, Carlson, Emily, Williams, Robin, Koirala, Samir, Buss, Bryan, Donahue, Matthew, Palm, Jennifer, Kollmann, Leslie, Holzbauer, Stacy, Levine, Min Z., Davis, Todd, Barnes, John R., Flannery, Brendan, Brammer, Lynnette, and Fry, Alicia

Subjects
Avian influenza -- Statistics -- Risk factors, Epidemics -- Statistics -- Risk factors -- United States, Zoonoses -- Statistics -- Risk factors, Health
Abstract

Infection with highly pathogenic avian influenza (HPAI) virus results in high mortality rates in chickens, gallinaceous birds, and some wild bird species (1). Potential for HPAI virus transmission and adaptation [...]

Published
2023
Full Text
View/download PDF

6. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020

Author

Shafer, Livvy, Ahmed, Faruque, Kim, Sara, Wernli, Karen J., Jackson, Michael L., Nowalk, Mary Patricia, Bear, Todd, Zimmerman, Richard K., Martin, Emily T., Monto, Arnold S., Gaglani, Manjusha, Reis, Michael, Chung, Jessie R., Flannery, Brendan, and Uzicanin, Amra

Subjects
Epidemics -- Surveys -- United States, Telecommuting -- Surveys -- Health aspects, Presenteeism (Labor) -- Surveys -- Health aspects, Telecommuting, Health
Abstract

In response to the then-evolving COVID-19 pandemic, a public health emergency was declared in the United States on January 31, 2020, and several closure and containment policies were subsequently put [...]

Published
2023
Full Text
View/download PDF

7. Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness--United States

Author

Frutos, Aaron M., Price, Ashley M., Harker, Elizabeth, Reeves, Emily L., Ahmad, Haris M., Murugan, Vel, Martin, Emily T., House, Stacey, Saade, Elie A., Zimmerman, Richard K., Gaglani, Manjusha, Wernli, Karen J., Walter, Emmanuel B., Michaels, Marian G., Staat, Mary A., Weinberg, Geoffrey A., Selvarangan, Rangaraj, Boom, Julie A., Klein, Eileen J., Halasa, Natasha B., Ginde, Adit A., Gibbs, Kevin W., Zhu, Yuwei, Self, Wesley H., Tartof, Sara Y., Klein, Nicola P., Dascomb, Kristin, DeSilva, Malini B., Weber, Zachary A., Yang, Duck-Hye, Ball, Sarah W., Surie, Diya, DeCuir, Jennifer, Dawood, Fatimah S., Moline, Heidi L., Toepfer, Ariana P., Clopper, Benjamin R., Link-Gelles, Ruth, Payne, Amanda B., Chung, Jessie R., Flannery, Brendan, Lewis, Nathaniel M., Olson, Samantha M., Adams, Katherine, Tenforde, Mark W., Garg, Shikha, Grohskopf, Lisa A., Reed, Carrie, and Ellington, Sascha

Subjects
United States. National Institutes of Health, Merck & Company Inc., Pfizer Inc., Vaccination -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Influenza vaccines -- Health aspects, Influenza -- Health aspects, Medical colleges -- Health aspects, Children -- Health aspects, Health, Vanderbilt University. Medical Center
Abstract

Introduction CDC's Advisory Committee on Immunization Practices recommends annual influenza vaccination for all persons aged [greater than or equal to]6 months (1). During previous influenza seasons, influenza vaccination prevented hundreds [...]

Published
2024

8. Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022.

Author

Sumner, Kelsey M, Yadav, Ruchi, Noble, Emma K, Sandford, Ryan, Joshi, Devyani, Tartof, Sara Y, Wernli, Karen J, Martin, Emily T, Gaglani, Manjusha, Zimmerman, Richard K, Talbot, H Keipp, Grijalva, Carlos G, Belongia, Edward A, Chung, Jessie R, Rogier, Eric, Coughlin, Melissa M, and Flannery, Brendan

Subjects
COVID-19, COVID-19 pandemic, VACCINE effectiveness, INFLUENZA vaccines, PROTEIN receptors
Abstract

Background We assessed associations between binding antibody (bAb) concentration <5 days from symptom onset and testing positive for COVID-19 among patients in a test-negative study. Methods From October 2021 to June 2022, study sites in 7 states enrolled patients aged ≥6 months presenting with acute respiratory illness. Respiratory specimens were tested for SARS-CoV-2. In blood specimens, we measured concentrations of anti-SARS-CoV-2 antibodies against the spike protein receptor binding domain (RBD) and nucleocapsid antigens from the ancestral strain in standardized bAb units (BAU). Percentage change in odds of COVID-19 by increasing anti-RBD bAb was estimated via logistic regression as (1 – adjusted odds ratio of COVID-19) × 100, adjusting for COVID-19 mRNA vaccine doses, age, site, and high-risk exposure. Results Out of 2018 symptomatic patients, 662 (33%) tested positive for acute SARS-CoV-2 infection. Geometric mean RBD bAb levels were lower among COVID-19 cases than SARS-CoV-2 test-negative controls during the Delta-predominant period (112 vs 498 BAU/mL) and Omicron-predominant period (823 vs 1189 BAU/mL). Acute-phase ancestral spike RBD bAb levels associated with 50% lower odds of COVID-19 were 1968 BAU/mL against Delta and 3375 BAU/mL against Omicron; thresholds may differ in other laboratories. Conclusions During acute illness, antibody concentrations against ancestral spike RBD were associated with protection against COVID-19. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Antibody Response to Symptomatic Infection With SARS‐CoV‐2 Omicron Variant Viruses, December 2021–June 2022.

Author

Sandford, Ryan, Yadav, Ruchi, Noble, Emma K., Sumner, Kelsey, Joshi, Devyani, Tartof, Sara Y., Wernli, Karen J., Martin, Emily T., Gaglani, Manjusha, Zimmerman, Richard K., Talbot, H. Keipp, Grijalva, Carlos G., Belongia, Edward A., Carlson, Christina, Coughlin, Melissa, Flannery, Brendan, Pearce, Brad, and Rogier, Eric

Subjects
SARS-CoV-2 Omicron variant, ANTIBODY formation, HUMORAL immunity, PROTEIN receptors, ACUTE diseases, DEEP brain stimulation
Abstract

We describe humoral immune responses in 105 ambulatory patients with laboratory‐confirmed SARS‐CoV‐2 Omicron variant infection. In dried blood spot (DBS) collected within 5 days of illness onset and during convalescence, we measured binding antibody (bAb) against ancestral spike protein receptor binding domain (RBD) and nucleocapsid (N) protein using a commercial multiplex bead assay. Geometric mean bAb concentrations against RBD increased by a factor of 2.5 from 1258 to 3189 units/mL and by a factor of 47 against N protein from 5.5 to 259 units/mL between acute illness and convalescence; lower concentrations were associated with greater geometric mean ratios. Paired DBS specimens may be used to evaluate humoral response to SARS‐CoV‐2 infection. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities — United States, July 2020

Author

IVY Network Investigators; CDC COVID-19 Response Team, Fisher, Kiva A., Olson, Samantha M., Tenforde, Mark W., Feldstein, Leora R., Lindsell, Christopher J., Shapiro, Nathan I., Files, D. Clark, Gibbs, Kevin W., Erickson, Heidi L., Prekker, Matthew E., Steingrub, Jay S., Exline, Matthew C., Henning, Daniel J., Wilson, Jennifer G., Brown, Samuel M., Peltan, Ithan D., Rice, Todd W., Hager, David N., Ginde, Adit A., Talbot, H. Keipp, Casey, Jonathan D., Grijalva, Carlos G., Flannery, Brendan, Patel, Manish M., and Self, Wesley H.

Published
2020

12. Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020

Author

IVY Network Investigators, CDC COVID-19 Response Team, Fisher, Kiva A., Tenforde, Mark W., Feldstein, Leora R., Lindsell, Christopher J., Shapiro, Nathan I., Files, D. Clark, Gibbs, Kevin W., Erickson, Heidi L., Prekker, Matthew E., Steingrub, Jay S., Exline, Matthew C., Henning, Daniel J., Wilson, Jennifer G., Brown, Samuel M., Peltan, Ithan D., Rice, Todd W., Hager, David N., Ginde, Adit A., Talbot, H. Keipp, Casey, Jonathan D., Grijalva, Carlos G., Flannery, Brendan, Patel, Manish M., and Self, Wesley H.

Published
2020

13. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020

Author

Dawood, Fatimah S., Chung, Jessie R., Kim, Sara S., Zimmerman, Richard K., Nowalk, Mary Patricia, Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Dunnigan, Kayan, Foust, Angie, Sessions, Wendy, DaSilva, Juliana, Le, Shoshona, Stark, Thomas, Kondor, Rebecca J., Barnes, John R., Wentworth, David E., Brammer, Lynnette, Fry, Alicia M., Patel, Manish M., and Flannery, Brendan

Published
2020

14. Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020–February 2021

Author

Hobbs, Charlotte V., Kim, Sara S., Vemula, Preeti, Inagaki, Kengo, Harrison, Virginia A., Malloch, Lacy, Martin, Lora M., Singh, Gurbaksh, Agana, Urita, Williams, John M., Patterson, Kayla, Kittle, Theresa, Byers, Paul, Palmer, April, Santos, Roberto P., Dhanrajani, Anita, Stephenson, Meagan, Hung, Leroy, Hankins, Phillip, Thornburg, Nathalie, Drobeniuc, Jan, and Flannery, Brendan

Published
2022
Full Text
View/download PDF

15. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019

Author

Doyle, Joshua D., Chung, Jessie R., Kim, Sara S., Gaglani, Manjusha, Raiyani, Chandni, Zimmerman, Richard K., Nowalk, Mary Patricia, Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Foust, Angie, Sessions, Wendy, Berman, LaShondra, Garten, Rebecca J., Barnes, John R., Wentworth, David E., Fry, Alicia M., Patel, Manish M., and Flannery, Brendan

Published
2019

17. Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States

Author

Patel, Manish, Chen, Jufu, Kim, Sara, Garg, Shikha, Flannery, Brendan, Haddadin, Zaid, Rankin, Danielle, Halasa, Natasha, Talbot, H. Keipp, and Reed, Carrie

Subjects
Influenza vaccines -- Usage, Disease susceptibility -- Care and treatment, Medical research -- Analysis -- Usage, Influenza -- Care and treatment, Immunotherapy -- Analysis -- Usage, Immune response -- Usage -- Analysis, Health
Abstract

Influenza is a common cause of illness and death in the United States and affects persons of all ages (1). Risk for complications from infection is higher in subpopulations, such [...]

Published
2020
Full Text
View/download PDF

18. Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018

Author

Ahmed, Faruque, Kim, Sara, Nowalk, Mary Patricia, King, Jennifer P., VanWormer, Jeffrey J., Gaglani, Manjusha, Zimmerman, Richard K., Bear, Todd, Jackson, Michael L., Jackson, Lisa A., Martin, Emily, Cheng, Caroline, Flannery, Brendan, Chung, Jessie R., and Uzicanin, Amra

Subjects
United States. Centers for Disease Control and Prevention, Influenza -- Comparative analysis, Telecommuting -- Comparative analysis, Retirement benefits, Workers, Respiratory tract diseases, Diseases, Telecommuting, Health
Abstract

The annual economic burden of influenza in the United States, depending on the severity of the influenza season, ranges from $15 billion to $64 billion, of which lost productivity accounts [...]

Published
2020
Full Text
View/download PDF

20. Early and Increased Influenza Activity Among Children--Tennessee, 2022-23 Influenza Season

Author

Thomas, Christine M., White, Elizabeth B., Kojima, Noah, Fill, Mary-Margaret A., Hanna, Samir, Jones, Timothy F., Newhouse, Caitlin N., Orejuela, Kelly, Roth, Emma, Winders, Sarah, Chandler, Daniel R., Grijalva, Carlos G., Schaffner, William, Schmitz, Jonathan E., DaSilva, Juliana, Kirby, Marie K., Mellis, Alexandra M., Rolfes, Melissa A., Sumner, Kelsey M., Flannery, Brendan, Talbot, H. Keipp, and Dunn, John R.

Subjects
United States. Department of Health and Human Services, Medical research, Medicine, Experimental, Pediatrics, Genomics, Influenza viruses, Influenza, Health, Vanderbilt University. Medical Center
Abstract

Influenza seasons typically begin in October and peak between December and February (1); however, the 2022-23 influenza season in Tennessee began in late September and was characterized by high pediatric [...]

Published
2023

21. Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network.

Author

Adams, Katherine, Weber, Zachary A, Yang, Duck-Hye, Klein, Nicola P, DeSilva, Malini B, Dascomb, Kristin, Irving, Stephanie A, Naleway, Allison L, Rao, Suchitra, Gaglani, Manjusha, Flannery, Brendan, Garg, Shikha, Kharbanda, Anupam B, Grannis, Shaun J, Ong, Toan C, Embi, Peter J, Natarajan, Karthik, Fireman, Bruce, Zerbo, Ousseny, and Goddard, Kristin

Subjects
MEDICAL care use, IMMUNIZATION, RESEARCH funding, INTERPROFESSIONAL relations, INFLUENZA vaccines, VACCINE effectiveness, HOSPITAL care, OUTPATIENT medical care, HOSPITAL emergency services, DESCRIPTIVE statistics, ODDS ratio, ELECTRONIC health records, INFLUENZA A virus, H3N2 subtype, DATA analysis software, CONFIDENCE intervals, SEASONAL influenza, EVALUATION, ADOLESCENCE, CHILDREN
Abstract

Background During the 2022–2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010–2011. Influenza A/H3N2 infections were predominant. Methods We analyzed acute respiratory illness (ARI)–associated emergency department or urgent care (ED/UC) encounters or hospitalizations at 3 health systems among children and adolescents aged 6 months–17 years who had influenza molecular testing during October 2022–March 2023. We estimated influenza A vaccine effectiveness (VE) using a test-negative approach. The odds of vaccination among influenza-A–positive cases and influenza-negative controls were compared after adjusting for confounders and applying inverse-propensity-to-be-vaccinated weights. We developed overall and age-stratified VE models. Results Overall, 13 547 of 44 787 (30.2%) eligible ED/UC encounters and 263 of 1862 (14.1%) hospitalizations were influenza-A–positive cases. Among ED/UC patients, 15.2% of influenza-positive versus 27.1% of influenza-negative patients were vaccinated; VE was 48% (95% confidence interval [CI], 44–52%) overall, 53% (95% CI, 47–58%) among children aged 6 months–4 years, and 38% (95% CI, 30–45%) among those aged 9–17 years. Among hospitalizations, 17.5% of influenza-positive versus 33.4% of influenza-negative patients were vaccinated; VE was 40% (95% CI, 6–61%) overall, 56% (95% CI, 23–75%) among children ages 6 months–4 years, and 46% (95% CI, 2–70%) among those 5–17 years. Conclusions During the 2022–2023 influenza season, vaccination reduced the risk of influenza-associated ED/UC encounters and hospitalizations by almost half (overall VE, 40–48%). Influenza vaccination is a critical tool to prevent moderate-to-severe influenza illness in children and adolescents. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.

Author

King, Jennifer P., Chung, Jessie R., Donahue, James G., Martin, Emily T., Leis, Aleda M., Monto, Arnold S., Gaglani, Manjusha, Dunnigan, Kayan, Raiyani, Chandni, Saydah, Sharon, Flannery, Brendan, and Belongia, Edward A.

Subjects
VACCINE effectiveness, INFLUENZA vaccines, PHYSICAL mobility, COVID-19 vaccines, POST-acute COVID-19 syndrome, INTELLECTUAL disabilities
Abstract

Background: Symptoms of COVID-19 including fatigue and dyspnea, may persist for weeks to months after SARS-CoV-2 infection. This study compared self-reported disability among SARS-CoV-2-positive and negative persons with mild to moderate COVID-19-like illness who presented for outpatient care before widespread COVID-19 vaccination. Methods: Unvaccinated adults with COVID-19-like illness enrolled within 10 days of illness onset at three US Flu Vaccine Effectiveness Network sites were tested for SARS-CoV-2 by molecular assay. Enrollees completed an enrollment questionnaire and two follow-up surveys (7–24 days and 2–7 months after illness onset) online or by phone to assess illness characteristics and health status. The second follow-up survey included questions measuring global health, physical function, fatigue, and dyspnea. Scores in the four domains were compared by participants' SARS-CoV-2 test results in univariate analysis and multivariable Gamma regression. Results: During September 22, 2020 – February 13, 2021, 2712 eligible adults were enrolled, 1541 completed the first follow-up survey, and 650 completed the second follow-up survey. SARS-CoV-2-positive participants were more likely to report fever at acute illness but were otherwise comparable to SARS-CoV-2-negative participants. At first follow-up, SARS-CoV-2-positive participants were less likely to have reported fully or mostly recovered from their illness compared to SARS-CoV-2-negative participants. At second follow-up, no differences by SARS-CoV-2 test results were detected in the four domains in the multivariable model. Conclusion: Self-reported disability was similar among outpatient SARS-CoV-2-positive and -negative adults 2–7 months after illness onset. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

Author

Flannery, Brendan, Smith, Catherine, Garten, Rebecca J., Levine, Min Z., Chung, Jessie R., Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Murthy, Kempapura, Zimmerman, Richard, Nowalk, Mary Patricia, Griffin, Marie R., Talbot, H. Keipp, Treanor, John J., Wentworth, David E., and Fry, Alicia M.

Published
2018

25. Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016

Author

Stewart, Rebekah J., Flannery, Brendan, Chung, Jessie R., Gaglani, Manjusha, Reis, Michael, Zimmerman, Richard K., Nowalk, Mary Patricia, Jackson, Lisa, Jackson, Michael L., Monto, Arnold S., Martin, Emily T., Belongia, Edward A., McLean, Huong Q., Fry, Alicia M., and Havers, Fiona P.

Published
2018

26. Update : Influenza Activity — United States, October 1, 2017–February 3, 2018

Author

Budd, Alicia P., Wentworth, David E., Blanton, Lenee, Elal, Anwar Isa Abd, Alabi, Noreen, Barnes, John, Brammer, Lynnette, Burns, Erin, Cummings, Charisse N., Davis, Todd, Flannery, Brendan, Fry, Alicia M., Garg, Shikha, Garten, Rebecca, Gubareva, Larisa, Jang, Yunho, Kniss, Krista, Kramer, Natalie, Lindstrom, Stephen, Mustaquim, Desiree, O’Halloran, Alissa, Olsen, Sonja J., Sessions, Wendy, Taylor, Calli, Xu, Xiyan, Dugan, Vivien G., Katz, Jacqueline, and Jernigan, Daniel

Published
2018

28. Update : Influenza Activity — United States, October 1–November 25, 2017

Author

Dugan, Vivien G., Blanton, Lenee, Elal, Anwar Isa Abd, Alabi, Noreen, Barnes, John, Brammer, Lynnette, Burns, Erin, Cummings, Charisse N., Davis, Todd, Flannery, Brendan, Fry, Alicia M., Garg, Shikha, Garten, Rebecca, Gubareva, Larisa, Jang, Yunho, Kniss, Krista, Kramer, Natalie, Lindstrom, Stephen, Mustaquim, Desiree, O’Halloran, Alissa, Olsen, Sonja J., Sessions, Wendy, Taylor, Calli, Trock, Susan, Xu, Xiyan, Wentworth, David E., Katz, Jacqueline, and Jernigan, Daniel

Published
2017

33. Perception of Local COVID-19 Transmission and Use of Preventive Behaviors Among Adults with Recent SARS-CoV-2 Infection--Illinois and Michigan, June 1-July 31, 2022

Author

Czeisler, Mark E., Lane, Rashon I., Orellana, Robert C., Lundeen, Kristen, Macomber, Kathryn, Collins, Jim, Varma, Prerna, Booker, Lauren A., Rajaratnam, Shantha M.W., Howard, Mark E., Czeisler, Charles A., Flannery, Brendan, and Weaver, Matthew D.

Subjects
Infection, Adults, Resveratrol, Health
Abstract

During the early stages of the COVID-19 pandemic, use of preventive behaviors was associated with perceived risk for contracting SARS-CoV-2 infection (1,2). Over time, perceived risk has declined along with [...]

Published
2022

37. Update : Influenza Activity in the United States During the 2016–17 Season and Composition of the 2017–18 Influenza Vaccine

Author

Blanton, Lenee, Alabi, Noreen, Mustaquim, Desiree, Taylor, Calli, Kniss, Krista, Kramer, Natalie, Budd, Alicia, Garg, Shikha, Cummings, Charisse N., Chung, Jessie, Flannery, Brendan, Fry, Alicia M., Sessions, Wendy, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Dugan, Vivien, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2017

40. Update : Influenza Activity — United States, October 2–December 17, 2016

Author

Shang, Mei, Blanton, Lenee, Kniss, Krista, Mustaquim, Desiree, Alabi, Noreen, Barnes, Stephen, Budd, Alicia, Davlin, Stacy L., Kramer, Natalie, Garg, Shikha, Cummings, Charisse N., Flannery, Brendan, Fry, Alicia M., Grohskopf, Lisa A., Olsen, Sonja J., Bresee, Joseph, Sessions, Wendy, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2016

44. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015

Author

Flannery, Brendan, Zimmerman, Richard K., Gubareva, Larisa V., Garten, Rebecca J., Chung, Jessie R., Nowalk, Mary Patricia, Jackson, Michael L., Jackson, Lisa A., Monto, Arnold S., Ohmit, Suzanne E., Belongia, Edward A., McLean, Huong Q., Gaglani, Manjusha, Piedra, Pedro A., Mishin, Vasiliy P., Chesnokov, Anton P., Spencer, Sarah, Thaker, Swathi N., Barnes, John R., Foust, Angie, Sessions, Wendy, Xu, Xiyan, Katz, Jacqueline, and Fry, Alicia M.

Published
2016

45. Update : Influenza Activity — United States and Worldwide, May 22–September 10, 2016

Author

Budd, Alicia, Blanton, Lenee, Kniss, Krista, Smith, Sophie, Mustaquim, Desiree, Davlin, Stacy L., Kramer, Natalie, Flannery, Brendan, Fry, Alicia M., Grohskopf, Lisa A., Olsen, Sonja J., Bresee, Joseph, Sessions, Wendy, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2016

46. Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine

Author

Davlin, Stacy L., Blanton, Lenee, Kniss, Krista, Mustaquim, Desiree, Smith, Sophie, Kramer, Natalie, Cohen, Jessica, Cummings, Charisse Nitura, Garg, Shikha, Flannery, Brendan, Fry, Alicia M., Grohskopf, Lisa A., Bresee, Joseph, Wallis, Teresa, Sessions, Wendy, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2016

47. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States

Author

Gaglani, Manjusha, Pruszynski, Jessica, Murthy, Kempapura, Clipper, Lydia, Robertson, Anne, Reis, Michael, Chung, Jessie R., Piedra, Pedro A., Avadhanula, Vasanthi, Nowalk, Mary Patricia, Zimmerman, Richard K., Jackson, Michael L., Jackson, Lisa A., Petrie, Joshua G., Ohmit, Suzanne E., Monto, Arnold S., McLean, Huong Q., Belongia, Edward A., Fry, Alicia M., and Flannery, Brendan

Published
2016

48. Update : Influenza Activity — United States, October 4, 2015–February 6, 2016

Author

Russell, Kate, Blanton, Lenee, Kniss, Krista, Mustaquim, Desiree, Smith, Sophie, Cohen, Jessica, Garg, Shikha, Flannery, Brendan, Fry, Alicia M., Grohskopf, Lisa A., Bresee, Joseph, Wallis, Teresa, Sessions, Wendy, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2016

50. Update : Influenza Activity — United States, October 4–November 28, 2015

Author

Smith, Sophie, Blanton, Lenee, Kniss, Krista, Mustaquim, Desiree, Steffens, Craig, Reed, Carrie, Bramley, Anna, Flannery, Brendan, Fry, Alicia M., Grohskopf, Lisa A., Bresee, Joseph, Wallis, Teresa, Garten, Rebecca, Xu, Xiyan, Elal, Anwar Isa Abd, Gubareva, Larisa, Barnes, John, Wentworth, David E., Burns, Erin, Katz, Jacqueline, Jernigan, Daniel, and Brammer, Lynnette

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results